Seqens Seqens

X

Find Radio Compass News for MolPort-002-051-769

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 0.5MG
  • TABLET;ORAL - 1MG
  • TABLET;ORAL - 2MG
  • INJECTABLE;INJECTION - 2MG/ML
  • INJECTABLE;INJECTION - 4MG/ML

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf

FDA
07 Jun 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf

FDA
24 May 2023

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hikma-pharmaceuticals-usa-inc-lorazepam-2mg-slash-ml-injection-lorazepam-4mg-slash-ml-injection-unlicensed-medicines

GOVUK
30 Aug 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-17-2022-1660735823.pdf

FDA
17 Aug 2022

https://www.fda.gov/news-events/press-announcements/fda-requiring-labeling-changes-benzodiazepines#:~:text=The%20U.S.%20Food%20and%20Drug,misuse%2C%20addiction%2C%20physical%20dependence%20and

FDA.GOV
23 Sep 2020

https://www.reuters.com/article/us-health-benzodiazepenes-pain/use-of-valium-and-xanax-for-pain-rising-in-u-s-idUSKCN1PQ5GV?feedType=RSS&feedName=healthNews

Lisa Rapaport REUTERS
04 Jan 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-27-2017-1514352313.pdf

FDA
27 Dec 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203572

FDA
27 Dec 2017

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2017-1511935547.pdf

FDA
29 Nov 2017

https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticals-issues-voluntary-nationwide-recall-of-lorazepam-oral-concentrate-usp-2mgml-1502940780.pdf

FDA
17 Aug 2017

http://www.prnewswire.com/news-releases/amneal-pharmaceuticals-issues-voluntary-nationwide-recall-of-lorazepam-oral-concentrate-usp-2mgml-due-to-misprinted-dosing-droppers-supplied-with-the-product-300504255.html

PR NEWSWIRE
15 Aug 2017

http://www.in-pharmatechnologist.com/Regulatory-Safety/Pfizer-pulls-lorazepam-pill-batch-in-Japan-due-to-faulty-engraving

G. MacDonald IN PHARMATECHNOLOGIST
11 Aug 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200217

FDA
07 Apr 2017

http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/62300r-eng.php

HEALTH CANADA
22 Feb 2017

http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/62296r-eng.php

HEALTH CANADA
22 Feb 2017

http://www.fiercepharma.com/pharma/medicare-medcaid-pony-up-for-big-price-hikes-2015-data-show

Eric Sagonowsky FIERCE PHARMA
15 Nov 2016

http://www.reuters.com/article/us-health-rxdrugs-benzodiazepine-overdos-idUSKCN0VZ2TU

Madeline Kennedy REUTERS
26 Feb 2016

http://www.forbes.com/sites/alicegwalton/2016/02/04/anxiety-meds-valium-xanax-and-ativan-may-not-lead-to-dementia-suggests-study/?ss=pharma-healthcare#6d0dbd01408a

Alice G. Walton FORBES
04 Feb 2016

http://globenewswire.com/news-release/2015/12/03/792502/10157771/en/Sandoz-Canada-Launches-a-New-Concentration-of-T-C-Lorazepam-Injection-USP.html

NASDAQ
03 Dec 2015

http://www.alternet.org/drugs/deadliest-prescription-drug-america

Christopher Byron ALTERNET
16 Feb 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY